Article
Stem cell‐based therapy for Parkinson's disease
1 Jan 2005
Abstract excerpt
Motor dysfunctions in Parkinson's disease are considered to be primarily due to the degeneration of dopaminergic neurons in the substantia nigra pars compacta. Pharmacological therapies based on the principle of dopamine replacement are extremely valuable, but suffer from two main drawbacks: troubling side effects (e.g. dyskinesia) and loss of efficacy with disease progression. Transplantation of embryonic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
